Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute), 7832-7833 [2017-01403]
Download as PDF
<![CDATA[
7832
Federal Register / Vol. 82, No. 13 / Monday, January 23, 2017 / Notices
are cooperating agencies for NEPA and
signatories for NHPA.
Frances Perkins Building Exchange
The new DOL HQ would be built by
a developer, on one of the acceptable
sites identified by GSA and DOL
through a site selection process that
concluded with an announcement of
shortlisted sites on November 29, 2016.
Following construction of the new DOL
HQ and acceptance of the DOL HQ by
GSA, the title to Frances Perkins will be
transferred to the developer to offset the
cost of the new DOL HQ.
mstockstill on DSK3G9T082PROD with NOTICES
Alternatives Under Consideration
As part of the EIS, GSA will study the
impacts of developing approximately 1
million rentable square feet
consolidated DOL HQ on three site
alternatives. These sites are:
• Site 1 NoMa—this site is located at
the intersection of North Capitol Street
and New York Avenue in the Northeast
quadrant of Washington, DC.
• Site 2 Capitol Riverfront—this site
is located at the intersection of M Street
and South Capitol Street in the
Southwest quadrant of Washington, DC.
• Site 3 Poplar Point—this site is
located in Anacostia and bordered by
interstate 295, Howard Road and
Suitland Parkway in the Southeast
quadrant of Washington, DC.
Additionally, GSA will study
potential indirect impacts related to the
exchange of the Frances Perkins parcel.
GSA also will evaluate a ‘‘No Action
Alternative’’, in which DOL would
remain in its current locations without
consolidation at a new permanent
location.
Resource areas to be addressed in the
EIS will include, but not be limited to:
air quality, noise, land use,
socioeconomics, traffic and
transportation, infrastructure and
community services, natural resources,
biological resources, cultural resources,
and safety and environmental hazards.
The analysis will evaluate direct,
indirect, and cumulative impacts.
Relevant and reasonable measures that
could avoid or mitigate environmental
effects will also be analyzed. In
conjunction with the NEPA process,
GSA will undertake any consultations
required by applicable laws or
regulations, including NHPA.
Scoping Process
In accordance with NEPA, a scoping
process will be conducted to: (1) Aid in
determining the alternatives to be
considered and the scope of issues to be
addressed; and (2) identify the
significant environmental issues related
to the proposed DOL HQ consolidation
VerDate Sep<11>2014
19:02 Jan 19, 2017
Jkt 241001
that should be addressed during the
preparation of the Draft EIS. Scoping
will be accomplished through a series of
public scoping meetings; mail and email
correspondence to potentially interested
persons, agencies, and organizations;
social media and other web-based
communications; and meetings with
agencies having an interest in the DOL
HQ consolidation. GSA is also using the
NEPA scoping process to facilitate
consultation with the public under
Section 106 of the NHPA (36 CFR part
800). GSA welcomes comments from the
public to ensure that the agency takes
into account the effects of the proposed
action on historic and cultural
resources.
GSA will publish announcement
notices in the Washington Post and the
Washington Business Journal
approximately one to two weeks prior to
the public scoping meetings. After
receiving scoping comments, GSA will
respond to them in the EIS and through
the Section 106 consultation process.
GSA will make available to the public
a comment/response matrix
summarizing the scoping and Section
106 comments in the Draft and Final
EIS.
Written Comments: Agencies and the
public are encouraged to provide
written comments on the scoping issues
related to the EIS for the proposed DOL
HQ consolidation in addition to, or in
lieu of, providing comments at the
public scoping meeting. Written
comments must be postmarked no later
than March 1, 2017, and sent to the
General Services Administration,
Attention: Alexis Gray, NEPA
Compliance Specialist, 301 7th Street
SW., Room 4004, Washington, DC
20407. Email: alexis.gray@gsa.gov using
the subject line: DOL NEPA Scoping
Comment. Comments may also be
submitted via the Web site:
www.gsa.gov/dolhqexchange.
Dated: January 13, 2017.
Mina Wright,
Director, Office of Planning and Design
Quality, National Capital Region, Public
Buildings Service, General Services
Administration.
[FR Doc. 2017–01380 Filed 1–19–17; 8:45 am]
BILLING CODE 6820–Y1–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH or Institute)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meetings.
Times and Dates:
8:00 a.m.–5:00 p.m., EST, February
14, 2017 (Closed).
8:00 a.m.–5:00 p.m., EST, February
15, 2017 (Closed).
8:00 a.m.–5:00 p.m., EST, February
16, 2017 (Closed).
Place: Embassy Suites, 1900 Diagonal
Road, Alexandria, Virginia 22314,
Telephone: 703–684–5900, Fax: 703–
684–0653.
Purpose: The Safety and Occupational
Health Study Section will review,
discuss, and evaluate grant
application(s) received in response to
the Institute’s standard grants review
and funding cycles pertaining to
research issues in occupational safety
and health, and allied areas.
It is the intent of NIOSH to support
broad-based research endeavors in
keeping with the Institute’s program
goals. This will lead to improved
understanding and appreciation for the
magnitude of the aggregate health
burden associated with occupational
injuries and illnesses, as well as to
support more focused research projects,
which will lead to improvements in the
delivery of occupational safety and
health services, and the prevention of
work-related injury and illness. It is
anticipated that research funded will
promote these program goals.
Matters for Dicussion: The meeting
will convene to address matters related
to the conduct of Study Section
business and for the study section to
consider safety and occupational healthrelated grant applications.
These portions of the meeting will be
closed to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d)
Public Law 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Price Connor, Ph.D., NIOSH Health
E:\FR\FM\23JAN1.SGM
23JAN1
Federal Register / Vol. 82, No. 13 / Monday, January 23, 2017 / Notices
Scientist, CDC, 2400 Executive Parkway,
Mailstop E–20, Atlanta, Georgia 30345;
Telephone: 404–498–2511; Fax: 404–
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
SUMMARY:
[FR Doc. 2017–01403 Filed 1–19–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics:
Notice of Charter Renewal
mstockstill on DSK3G9T082PROD with NOTICES
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, National
Center for Health Statistics, Department
of Health and Human Services, has been
renewed for a 2-year period through
January 19, 2019.
For information, contact Virginia
Cain, Ph.D., Designated Federal Officer,
Board of Scientific Counselors, National
Center for Health Statistics, Department
of Health and Human Services, 3311
Toledo Road, Room 2627, Mailstop P08,
Hyattsville, Maryland 20782, telephone
301/458–4395 or fax 301/458–4020.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2017–01402 Filed 1–19–17; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
19:02 Jan 19, 2017
Jkt 241001
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–262]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Comments on the collection(s) of
information must be received by the
OMB desk officer by February 22, 2017.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
DATES:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
7833
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Contract Year
2018 Plan Benefit Package (PBP)
Software and Formulary Submission;
Use: We require that Medicare
Advantage and Prescription Drug Plan
organizations submit a completed PBP
and formulary as part of the annual
bidding process. During this process,
organizations prepare their proposed
plan benefit packages for the upcoming
contract year and submit them to us for
review and approval. We publish
beneficiary education information using
a variety of formats. The specific
education initiatives that utilize PBP
and formulary data include web
application tools on www.medicare.gov
and the plan benefit insert in the
Medicare & You handbook. In addition,
organizations utilize the PBP data to
generate their Summary of Benefits
marketing information. Form Number:
CMS–R–262 (OMB control number
0938–0763); Frequency: Yearly; Affected
Public: Business or other for-profits and
Not-for-profit institutions; Number of
Respondents: 524; Total Annual
Responses: 5,185; Total Annual Hours:
50,619. (For policy questions regarding
this collection contact Kristy Holtje at
410–786–2209.)
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 82, Number 13 (Monday, January 23, 2017)]
[Notices]
[Pages 7832-7833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01403]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Safety and Occupational Health Study Section (SOHSS), National
Institute for Occupational Safety and Health (NIOSH or Institute)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meetings.
Times and Dates:
8:00 a.m.-5:00 p.m., EST, February 14, 2017 (Closed).
8:00 a.m.-5:00 p.m., EST, February 15, 2017 (Closed).
8:00 a.m.-5:00 p.m., EST, February 16, 2017 (Closed).
Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia
22314, Telephone: 703-684-5900, Fax: 703-684-0653.
Purpose: The Safety and Occupational Health Study Section will
review, discuss, and evaluate grant application(s) received in response
to the Institute's standard grants review and funding cycles pertaining
to research issues in occupational safety and health, and allied areas.
It is the intent of NIOSH to support broad-based research endeavors
in keeping with the Institute's program goals. This will lead to
improved understanding and appreciation for the magnitude of the
aggregate health burden associated with occupational injuries and
illnesses, as well as to support more focused research projects, which
will lead to improvements in the delivery of occupational safety and
health services, and the prevention of work-related injury and illness.
It is anticipated that research funded will promote these program
goals.
Matters for Dicussion: The meeting will convene to address matters
related to the conduct of Study Section business and for the study
section to consider safety and occupational health-related grant
applications.
These portions of the meeting will be closed to the public in
accordance with provisions set forth in Section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Director, Management
Analysis and Services Office, Centers for Disease Control and
Prevention, pursuant to Section 10(d) Public Law 92-463.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Price Connor, Ph.D., NIOSH
Health
[[Page 7833]]
Scientist, CDC, 2400 Executive Parkway, Mailstop E-20, Atlanta, Georgia
30345; Telephone: 404-498-2511; Fax: 404-498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-01403 Filed 1-19-17; 8:45 am]
BILLING CODE 4163-18-P
